Low serum Klotho reflects senile inflammation in middle-aged and elderly patients with coronary atherosclerosis

Qi Mao1, Mengyang Deng1, Jianhua Zhao1

  • 1Department of Cardiology, Institute of Cardiovascular Research, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.

Cytokine
|April 30, 2023
PubMed

Insights

Low serum Klotho levels indicate aging-related inflammation and are linked to the severity of coronary artery disease (CAD) in older adults. This finding highlights Klotho

Area of Science:

  • Gerontology
  • Immunology
  • Cardiology

Background:

  • Atherosclerosis is a chronic inflammatory disease.
  • The anti-aging protein Klotho's role in inflammation, particularly senile inflammation, remains unclear.
  • This study investigates Klotho's association with inflammation in elderly patients with coronary artery disease (CAD).

Purpose of the Study:

  • To ascertain the correlation of serum Klotho with inflammation markers in middle-aged and elderly patients with CAD.
  • To evaluate Klotho's relationship with circulating inflammatory markers and T-lymphocyte subsets.
  • To determine the predictive value of Klotho and inflammatory markers for significant CAD.

Main Methods:

  • Included 302 patients with confirmed CAD.
  • Measured serum Klotho, IL-6, and IL-8 concentrations.
  • Analyzed T-lymphocyte subsets (monocytes, CD4+/CD8+ ratio) via flow cytometry.

Main Results:

  • Serum Klotho independently predicted lower monocyte counts and CD4+/CD8+ ratio.
  • Klotho was independently associated with lower IL-6 and IL-8 levels.
  • Monocytes and CD4+/CD8+ ratio correlated with higher IL-6 and IL-8, independent of CRP.
  • IL-6, IL-8, and CD4+/CD8+ ratio showed excellent predictive performance for significant CAD.

Conclusions:

  • Decreased serum Klotho concentrations reflect senile inflammation.
  • Low Klotho levels are associated with the severity of CAD in middle-aged and elderly individuals.
  • Klotho may serve as a potential biomarker for inflammation and CAD severity.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
208
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
129
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
18
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
19
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.2K